Pretransplant fecal carriage of extended-spectrum β-lactamase-producing enterobacteriaceae and infection after liver transplant, France

Emerging Infectious Diseases

Volumn 18, Issue 6, 2012, Pages 908-916

  Bert, Frédéric ^a   Larroque, Béatrice ^a   Paugam Burtz, Catherine ^b   Dondero, Federica ^b,c   Durand, François ^a   Marcon, Estelle ^c   Belghiti, Jacques ^b   Moreau, Richard ^a   Nicolas Chanoine, Marie Hélène ^a,b,c  

^a BEAUJON HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; AGAR DIFFUSION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM CARRIER; BACTERIUM IDENTIFICATION; CITROBACTER FREUNDII; CITROBACTER KOSERI; CONTROLLED STUDY; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FECES ANALYSIS; FEMALE; FRANCE; HUMAN; INCIDENCE; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; LIVER GRAFT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; OBSERVATIONAL STUDY; POLYMERASE CHAIN REACTION; RISK FACTOR; SCREENING;

ADULT; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARRIER STATE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; FEMALE; HUMANS; INCIDENCE; INTRAABDOMINAL INFECTIONS; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MOLECULAR TYPING; RISK FACTORS; URINARY TRACT INFECTIONS;

EID: 84861213303     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1806.110139     Document Type: Article

References (38)

1. Cantón R, Coque TM. The CTX-M β-lactamase pandemic. Curr Opin Microbiol. 2006;9:466-75. http://dx.doi.org/10.1016/j.mib.2006.08.011
2. Pitout JD, Laupland KB. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health problem. Lancet Infect Dis. 2008;8:159-66. http://dx.doi.org/10.1016/S1473-3099(08)70041-0
3. Schwaber MJ, Navon-Venezia S, Schwartz D, Carmeli Y. High levels of antimicrobial coresistance among extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother. 2006;50:1257-62. http://dx.doi.org/10.1128/AAC.50.4.1257-1262.2006
4. Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum β-lactamase production in Enterobacteriaceae bacteremia: a systematic review and metaanalysis. J Antimicrob Chemother. 2007;60:913-20. http://dx.doi.org/10.1093/jac/dkm318
5. Tumbarello M, Sanguinetti M, Montuori E, Trecarichi EM, Posteraro B, Fiori B, et al. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother. 2007;51:1987-94. http://dx.doi.org/10.1128/AAC.01509-06
6. Rodríguez-Baño J, Picón E, Gijón P, Hernández JR, Cisneros JM, Peña C, et al. Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli. J Clin Microbiol. 2010;48:1726-31. http://dx.doi.org/10.1128/JCM.02353-09
7. Linares L, Cervera C, Cofán F, Lizaso D, Marco F, Ricart MJ, et al. Risk factors for infection with extended-spectrum and ampC β-lactamase-producing Gram-negative rods in renal transplantation. Am J Transplant. 2008;8:1000-5. http://dx.doi.org/10.1111/j.1600-6143.2008.02197.x
8. Pinheiro HS, Mituiassu AM, Carminatti M, Braga AM, Bastos MG. Urinary tract infection caused by extended-spectrum betalactamase- producing bacteria in kidney transplant patients. Transplant Proc. 2010;42:486-7. http://dx.doi.org/10.1016/j.transproceed.2010.02.002
9. Rubin RH. Infectious disease problems. In: Maddrey WC, Schiff ER, Sorell MF, editors. Transplantation of the liver. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 275-295.
10. George DL, Arnow PM, Fox AS, Baker AL, Thistlethwaite JR, Emond JC, et al. Bacterial infection as a complication of liver transplantation: epidemiology and risk factors. Rev Infect Dis. 1991;13:387-96. http://dx.doi.org/10.1093/clinids/13.3.387
11. Wade JJ, Rolando N, Hayllar K, Philpott-Howard J, Casewell MW, Williams R. Bacterial and fungal infections after liver transplantation: an analysis of 284 patients. Hepatology. 1995;21:1328-36. http://dx.doi.org/10.1002/hep.1840210517
12. Singh N, Wagener MM, Obman A, Cacciarelli TV, de Vera ME, Gayowski T. Bacteremias in liver transplant recipients: shift toward Gram-negative bacteria as predominant pathogens. Liver Transpl. 2004;10:844-9. http://dx.doi.org/10.1002/lt.20214
13. Bert F, Larroque B, Paugam-Burtz C, Janny S, Durand F, Dondero F, et al. Microbial epidemiology and outcome of bloodstream infections in liver transplant recipients: an analysis of 259 episodes. Liver Transpl. 2010;16:393-401.
14. García Prado ME, Matia EC, Ciuro FP, Díez-Canedo JS, Sousa Martín JM, Porras López FM, et al. Surgical site infection in liver transplant recipients: impact of the type of perioperative prophylaxis. Transplantation. 2008;85:1849-54. http://dx.doi.org/10.1097/TP.0b013e3181735407
15. Zhou JD, Guo JJ, Zhang Q, Chen Y, Zhu SH, Peng HY. Drug resistance of infectious pathogens after liver transplantation. Hepatobiliary Pancreat Dis Int. 2006;5:190-4.
16. Shi SH, Kong HS, Xu J, Zhang WJ, Jia CK, Wang WL, et al. Multidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients. Transpl Infect Dis. 2009;11:405-12. http://dx.doi.org/10.1111/j.1399-3062.2009.00421.x
17. Bert F, Bellier C, Lassel L, Lefranc V, Durand F, Belghiti J, et al. Risk factors for Staphylococcus aureus infection in liver transplant recipients. Liver Transpl. 2005;11:1093-9. http://dx.doi.org/10.1002/lt.20491
18. Bellier C, Bert F, Durand F, Retout S, Belghiti J, Mentré F, et al. Risk factors for Enterobacteriaceae bacteremia after liver transplantation. Transpl Int. 2008;21:755-63. http://dx.doi.org/10.1111/j.1432-2277.2008.00673.x
19. Reid GE, Grim SA, Sankary H, Benedetti E, Oberholzer J, Clark NM. Early intra-abdominal infections associated with orthotopic liver transplantation. Transplantation. 2009;87:1706-11. http://dx.doi.org/10.1097/TP.0b013e3181a60338
20. Weiss E, Dahmani S, Bert F, Janny S, Sommacale D, Dondero F, et al. Early-onset pneumonia after liver transplantation: microbiological fi ndings and therapeutic consequences. Liver Transpl. 2010;16:1178-85. http://dx.doi.org/10.1002/lt.22132
21. Horan TC, Gaynes RP. Surveillance of nosocomial infections. In: Mayhall CG, editor. Hospital epidemiology and infection control, 3rd ed. Baltimore: Lippincott Williams & Wilkins; 2004. p. 1659-702.
22. Garrec H, Drieux-Rouzet L, Golmard J-L, Jarlier V, Robert J. Comparison of nine phenotypic methods for detection of extended-spectrum β-lactamase production by Enterobacteriaceae. J Clin Microbiol. 2011;49:1048-57. http://dx.doi.org/10.1128/JCM.02130-10
23. Communiqué de la Société Française de Microbiologie [cited 2011 Aug 22]. http://www.sfm-microbiologie.org/pages/?page=746&id_page_rfurl http://www.sfm-microbiologie.org/pages/?page=746&id_page=182
24. Bert F, Johnson JR, Ouattara B, Lefl on-Guibout V, Johnston B, Marcon E, et al. Genetic diversity and virulence profi le of Escherichia coli isolates causing spontaneous bacterial peritonitis and bacteremia in patients with cirrhosis. J Clin Microbiol. 2010;48:2709-14. http://dx.doi.org/10.1128/JCM.00516-10
25. Endimiani A, Hujer AM, Hujer KM, Gatta JA, Schriver AC, Jacobs MR, et al. Evaluation of a commercial microarray system for detection of SHV-, TEM-, CTX-M, and KPC-type β-lactamase genes in Gram-negative isolates. J Clin Microbiol. 2010;48:2618-22. http://dx.doi.org/10.1128/JCM.00568-10
26. Naas T, Cuzon G, Truong H, Bernabeu S, Nordmann P. Evaluation of a DNA microarray, the Check-Points ESBL/KPC array, for rapid detection of TEM, SHV, and CTX-M extended-spectrum β-lactamases and KPC carbapenemases. Antimicrob Agents Chemother. 2010;54:3086-92. http://dx.doi.org/10.1128/AAC.01298-09
27. Valverde A, Coque TM, Sánchez-Moreno MP, Rollán A, Baquero F, Cantón R. Dramatic increase in prevalence of fecal carriage of extended- spectrum β-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol. 2004;42:4769-75. http://dx.doi.org/10.1128/JCM.42.10.4769-4775.2004
28. Rodríguez-Baño J, Alcalá JC, Cisneros JM, Grill F, Oliver A, Horcajada JP, et al. Community infections caused by extended- spectrum β-lactamase-producing Escherichia coli. Arch Intern Med. 2008;168:1897-902. http://dx.doi.org/10.1001/ archinte.168.17.1897
29. Ben-Ami R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I, et al. Infl ux of extended-spectrum β-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis. 2006;42:925-34. http://dx.doi.org/10.1086/500936
30. Ben-Ami R, Rodríguez-Baño J, Arslan H, Pitout JDD, Quentin C, Calbo ES, et al. A multinational survey of risk factors for infection with extended-spectrum β-lactamase producing Enterobacteriaceae in nonhospitalized patients. Clin Infect Dis. 2009;49:682-90. http://dx.doi.org/10.1086/604713
31. Harris AD, Mc Gregor JC, Johnson JA, Strauss SM, Moore AC, Standiford HC, et al. Risk factors for colonization with extendedspectrum β-lactamase-producing bacteria and intensive care unit admission. Emerg Infect Dis. 2007;13:1144-9.
32. Friedmann R, Raveh D, Zartzer E, Rudensky B, Broide E, Attias D, et al. Prospective evaluation of colonization with extended-spectrum β-lactamase (ESBL) -producing Enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBLproducing Enterobacteriaceae among patients during hospitalization. Infect Control Hosp Epidemiol. 2009;30:534-42. http://dx.doi.org/10.1086/597505
33. Martins IS, Pessoa-Silva CL, Nouer SA, Pessoa de Araujo EG, Ferreira AL, Riley LW, et al. Endemic extended-spectrum β-lactamase- producing Klebsiella pneumoniae at an intensive care unit: risk factors for colonization and infection. Microb Drug Resist. 2006;12:50-8. http://dx.doi.org/10.1089/mdr.2006.12.50
34. Reddy P, Malczynski M, Obias A, Reiner S, Jin N, Huang J, et al. Screening for extended-spectrum β-lactamase producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia. Clin Infect Dis. 2007;45:846-52. http://dx.doi.org/10.1086/521260
35. Arnan M, Gudiol C, Calatayud L, Liñares J, Dominguez MÁ, Ribera JM, et al. Risk factors for, and clinical relevance of, faecal extendedspectrum β-lactamase producing Escherichia coli (ESBLEC) carriage in neutropenic patients with haematological malignancies. Eur J Clin Microbiol Infect Dis. 2011;30:355-60. http://dx.doi.org/10.1007/s10096-010-1093-x
36. Harris AD, Kotetishvili M, Shurland S, Johnson JA, Morris JG, Nemoy LL, et al. How important is patient-to-patient transmission in extended-spectrum beta-lactamase Escherichia coli acquisition. Am J Infect Control. 2007;35:97-101. http://dx.doi.org/10.1016/j.ajic.2006.09.011
37. Peña C, Gudiol C, Tubau F, Saballs M, Pujol M, Dominguez MA, et al. Risk-factors for acquisition of extended-spectrum β-lactamase- producing Escherichia coli among hospitalised patients. Clin Microbiol Infect. 2006;12:279-84. http://dx.doi.org/10.1111/j.1469-0691.2005.01358.x
38. Sun H-Y, Cacciarelli TV, Singh N. Impact of pretransplant infections on clinical outcomes of liver transplant recipients. Liver Transpl. 2010;16:222-8. http://dx.doi.org/10.1002/lt.21982